Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis

BACKGROUND: This Bayesian network meta-analysis (NMA) was conducted to compare efficacy and safety of programmed death 1/ligand 1 (PD-1/L1) inhibitors in previous untreated advanced non-small cell lung cancer (NSCLC) patients. METHODS: Eligible studies evaluating first-line anti-PD-1/L1 based regime...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Liang, Hengrui, Lin, Guo, Wang, Wei, Huang, Jun, Yang, Yilin, Lan, Yuting, Wang, Runchen, Cui, Fei, Hao, Zhexue, Deng, Hongsheng, Zhao, Shen, Cheng, Bo, Xiong, Shan, Li, Jianfu, Li, Caichen, Liu, Jun, He, Jianxing, Liang, Wenhua
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225152/
https://ncbi.nlm.nih.gov/pubmed/32420059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.02.14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados